Engineered Human Hepatocyte Organoids Enable CRISPR-based Target Discovery and Drug Screening for Steatosis
[Nat Biotechnol] The human fetal liver cell-like organ is used to reveal the pathogenic mechanisms of non-alcoholic fatty liver disease, contributing to the study of the etiology and drug targets for ...